Skip to content

Clinical trials

Phase 3 Cachexia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cachexia Phase: Phase 3 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20022
20031
20041
20063
20091
20102
20113
20151
20192
20221
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated4
Not yet recruiting1
Recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology3
Helsinn Therapeutics (U.S.), Inc3
Helsinn Healthcare SA2
Par Pharmaceutical, Inc.2
Wake Forest University Health Sciences2
Bristol-Myers Squibb1
Changchun GeneScience Pharmaceutical Co., Ltd.1
Immunotec Inc.1
International Food Policy Research Institute1
M.D. Anderson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cachexia25
Anorexia11
Carcinoma, Non-Small-Cell Lung8
Neoplasms6
Body Weight4
Lung Neoplasms4
Weight Loss4
Body Weight Changes2
Lymphoma, Large-Cell, Anaplastic2
Acquired Immunodeficiency Syndrome1

Trials

Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.